Form 10-Q Trovagene, Inc. For: Mar 31

Go back to Form 10-Q Trovagene, Inc. For: Mar 31

Trovagene (TROV) Misses Q1 EPS by 7c

May 10, 2016 4:53 PM EDT

Trovagene (NASDAQ: TROV) reported Q1 EPS of ($0.36), $0.07 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $120 thousand versus the consensus estimate of $260 thousand.

For earnings history and earnings-related data on Trovagene (TROV) click here.

... More